Wu han SynBioLily Biotechnology Co.,Ltd.

WuHan SynBioLily Biotechnology Co., Ltd., founded in October 2021, is an innovation-driven biotech company at the intersection of AI and synthetic biology. Our founding team comes from world-renowned institutions such as Kyoto University, the University of California, and the Chinese Academy of Sciences. We specialize in AI-powered pathway design, leveraging a world-leading synthetic biology big data system to develop high-value, customized raw materials. Our end-to-end industrial platform spans intelligent bio-design, strain engineering, process development, pilot-scale purification, and ton-scale manufacturing — with 20-ton capacity scheduled for commercial supply by May 2025 through a listed partner with a market cap of over RMB 60 billion. Our flagship product line, known as “White + Black”, represents a new generation of premium bio-based ingredients. SynBioLily holds more than 10 patents and software copyrights, and is the official host of the Global AI + Synthetic Biology (GAS) initiative. We are committed to making raw material innovation smarter, faster, and more accessible — driving the future of bio-manufacturing.